Our Services
Medical Information
Helpful Resources
Published on: 7/10/2026
Steroids offer fast hive relief but don't fix the immune pathways behind chronic spontaneous urticaria (CSU), and long-term use carries serious health risks. Biologics like omalizumab target the underlying immune signals driving CSU, reducing flare frequency and minimizing steroid dependence.
Below, you'll find key guidance on when to request a biologic, how to navigate specialist referrals, insurance approval processes, and patient support programs that can lower out-of-pocket costs.
Because CSU symptoms overlap with other conditions and treatment paths vary widely, understanding what's actually driving your hives is the critical first step. A free, instant, online symptom check can help you clarify your symptoms, identify possible causes, and prepare informed questions for your doctor—so you can advocate confidently for the right treatment, whether that's a biologic referral or another next step.
Reviewed for medical accuracy: 07/09/2026
If you've ever felt frustrated because your primary care won't give anything but steroids for hives, you're not alone. Many people with chronic or stubborn hives (urticaria) leave the doctor's office armed only with short-term prednisone prescriptions, unsure of how to break the cycle of flare-ups. While steroids can help in the short term, they're not a long-term solution. Biologic therapies, on the other hand, can target the root cause of chronic hives, reduce flares and minimize steroid use.
In this article, we'll cover:
Hives are raised, itchy welts on the skin that result from an allergic reaction or immune system overdrive. They can appear anywhere on your body and vary in size.
CSU affects about 1% of the population and can significantly impact quality of life—disturbed sleep, stress, embarrassment and even days missed from work or school.
Guidelines from the American Academy of Dermatology and European Academy of Allergy and Clinical Immunology recommend:
These treatments work for most people. But if your hives continue despite optimized antihistamines, it's time to consider specialty care.
When your primary care won't give anything but steroids for hives, you may feel relieved at first—prednisone often stops itching fast. However:
Relying on steroids can become a vicious cycle: flare-up → prednisone → short relief → flare-up again. That cycle takes a toll on your body.
Biologics are advanced medications made from living cells. They target specific parts of your immune system, reducing hives at the source.
Clinical trials show omalizumab:
For patients who don't respond to omalizumab or have other medical needs, researchers are exploring:
These options may become available if omalizumab is insufficient or not tolerated.
Ask your doctor or allergist if you:
Biologics are generally well-tolerated. Common mild side effects include injection-site reactions and transient headaches.
If your primary care won't go beyond steroids, insist on a referral. Persistent hives warrant specialized evaluation and often biologic therapy.
While awaiting specialist care or starting biologics, you can:
These measures can ease discomfort and provide data to your specialist.
Struggling to determine whether your hives warrant immediate care or can wait for a specialist appointment? Use this free AI Symptom Checker to analyze your symptoms in minutes and get personalized guidance on when to seek treatment and what to discuss with your doctor.
While most hives are benign, seek immediate medical attention if you experience:
These may signal a life-threatening allergic reaction (anaphylaxis). Always speak to a doctor if you suspect anything serious.
Chronic hives don't have to define your life. With the right therapy—often a biologic—you can regain control, reduce flares and minimize steroid exposure. Talk to your doctor or specialist today about whether a biologic could be the next step in your hives treatment journey.
(References)
* Maurer, M., et al. Omalizumab in chronic spontaneous urticaria: a comprehensive review of clinical efficacy, safety, and patient-reported outcomes. *Allergy*. 2023 Feb;78(2):332-349. doi: 10.1111/all.15500. PMID: 36262447.
* Dogan, S., et al. Current and emerging therapies for chronic spontaneous urticaria: A review of recent evidence. *Front Immunol*. 2024 Jan 12;14:1340628. doi: 10.3389/fimmu.2023.1340628. PMID: 38274765; PMCID: PMC10816912.
* Tedeschi, A., et al. New Insights into the Management of Chronic Spontaneous Urticaria: The Role of Biologics. *J Clin Med*. 2022 Sep 27;11(19):5696. doi: 10.3390/jcm11195696. PMID: 36233596; PMCID: PMC9570887.
* Zuberbier, T., et al. Chronic spontaneous urticaria: Current concepts and future perspectives. *Allergy*. 2022 May;77(5):1413-1428. doi: 10.1111/all.15234. Epub 2022 Feb 7. PMID: 35084044; PMCID: PMC9291192.
* Al-Shaikh, H., et al. Long-term management of chronic spontaneous urticaria: current perspectives on treatment options and adherence. *J Asthma Allergy*. 2020 Nov 23;13:699-710. doi: 10.2147/JAA.S274537. PMID: 33262699; PMCID: PMC7688467.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.